Real-World Evidence Evaluation on the Lipid Profile, Therapeutic Goals, and Safety of the Fixed-Dose Combination of Rosuvastatin/Ezetimibe (Trezete®) in Dyslipidemia Patients.
Saved in:
| Title: | Real-World Evidence Evaluation on the Lipid Profile, Therapeutic Goals, and Safety of the Fixed-Dose Combination of Rosuvastatin/Ezetimibe (Trezete®) in Dyslipidemia Patients. |
|---|---|
| Authors: | Rodríguez-Saldaña, Joel1 (AUTHOR), Padilla-Padilla, Francisco2 (AUTHOR), Cardona-Muñoz, Ernesto G.3 (AUTHOR), Romero-Antonio, Yulia4 (AUTHOR), Arguedas-Núñez, María Marcela4 (AUTHOR), Sander-Padilla, José G.4 (AUTHOR), Martínez-Muñoz, Alberto4 (AUTHOR), Lugo-Sánchez, Laura A.4 (AUTHOR), Rodríguez-Vazquez, Ileana C.4 (AUTHOR), González-Canudas, Jorge4,5 (AUTHOR) |
| Source: | Cardiology Research & Practice. 9/10/2022, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
